Sun Pharma Q1 results: Net loss at Rs. 1,656 crores
Mumbai: To begin with, Sun Pharma Industries reported its Q1 results. So then, the firm reported a consolidated net loss of Rs. 1,655.60 crores in the June 2020 quarter. Earlier, in the year-ago period, it stood at Rs. 1,387.48 crores.
On the other hand, the revenue from operations stood at Rs. 7,467.19 crores. Comparatively, in the year-ago period, it stood at Rs. 8,259.30 crores. The profit of the company stood at Rs. 3,633.33 crores.
Besides, it charged Rs. 104.28 crores in its profit and loss statement to provide for Supreme Court’s judgment relating to central excise refund.
July 31st Stock Market Details:
On July 31st, both the Sensex and the Nifty traded at a bearish trend in the stock market. The Sensex lost 129.18 points and reached 37,606.89 levels with a 0.34% loss. On the other side, the Nifty lost 28.70 points and reached 11,073.45 levels with a 0.26% loss.
In the border market, the S&P BSE Midcap index gained 49.39 points with a 0.36% profit and reached 13,759.11 levels. Also, the S&P BSE Smallcap index gained 105.49 points with a 0.82% profit and reached a 13,021.76 level.
Besides, as of August 1st, the number of confirmed COVID-19 cases across India has reached 16,95,988. Also, the number of deaths in the country has reached 36,511.